SAN DIEGO, June 22 (Reuters) – China, which now conducts more clinical drug trials, opens new tab than the U.S., still lags in the quality and commercial reach of its biomedical science, according to a recent survey, opens new tab of senior U.S. leaders in industry and academia.
The poll, conducted by Cure Innovation Index, found that China is seen as the clear leader in two out of six sectors: clinical development and supply chain.
Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.
It found that the U.S. leads in moving experimental products through to large-scale production, capital and commercialization and talent. The two countries were viewed as tied in the domain of scientific discovery.
“The U.S. is still leading, but confidence is eroding. Most said they see China as an existential threat,” said Seema Kumar, CEO at Cure, which is an affiliate of investment firm Deerfield Management.
Of the 117 respondents, 85% said the U.S. lead will last 10 years or less. The survey findings were presented in San Diego on Monday at the annual meeting of the Biotechnology Innovation Organization.
In recent years, multinational pharmaceutical companies have augmented their pipelines with candidates developed in China, where costs are low, regulation is streamlined and some say government subsidies, opens new tab offer an unfair advantage.
By 2024, the U.S. share of early drug development programs had dropped to around 37% from 48%, opens new tab in 2015, while China’s share of the global total rose to over 32% from 8%, according to a study conducted by Georgetown University.
Drugmakers are licensing molecules from China for potential new medicines at an accelerating pace, betting they can turn upfront payments of as little as $80 million into multibillion-dollar treatments.
The trends have alarmed the U.S. government. The National Security Commission on Emerging Biotechnology in a December report, opens new tab warned that “China has systematically built a vertically integrated biotechnology ecosystem that is now in prime position to challenge U.S. leadership.”
US Funding raises Concern
U.S. health officials on Monday announced a program “to restore America’s leadership in clinical trials” through a series of measures designed to speed drug research.
The Biosecure Act, opens new tab, signed into law by President Donald Trump late last year, restricts federal agencies’ business dealings with non-U.S. biotechnology companies.
“China has speed, scale, manufacturing, development, execution, and the U.S. is better at scientific quality, talent, some work on the tech transfer, and most important of all, it has the access to the world’s most valuable healthcare market,” Kumar said.
“Commercialization is America’s superpower,” she said. “The buyer is in the U.S.”
The U.S. accounted for 53% of the global pharmaceutical market, opens new tab in 2025, up from 49% in 2021, according to Iqvia, which said Europe’s share was steady at 24% while the Asia-Pacific region dipped to 11% from 13%.
The Cure survey’s other major finding, Kumar said, is that rather than competition from China, respondents rated the growing threat of U.S. research funding cuts as the bigger concern.
“The U.S. has all of the right ingredients, but the way we have been funding probably needs to change,” Kumar said.
More needs to be done to secure financing at the National Institutes of Health and to modernize the nation’s clinical development infrastructure, which has not been addressed since the nearly 50-year-old Bayh-Dole Act, opens new tab, she said.
Reporting By Deena Beasley; Editing by Mark Porter and Bill Berkrot
News – Curated by Amanda Scott, Alias Group Creative
Follow her on Bluesky
Scientists Find a Berry Compound That Helps Muscle Cells Burn Fat
Pterostilbene, a compound found naturally in some foods, affects how skeletal muscles process fats by stabilizing a protein called PPARδ and increasing its signaling activity. Pterostilbene, a natural compound found in blueberries, grapes, and [...]
Two Hidden Forces Help Build the Human Brain Before Birth
Scientists have uncovered two surprising forces that help guide how the human brain forms before birth. Before birth, the human brain is shaped in large part by an unusual class of stem cells known [...]
Researchers Uncover a Hidden Trigger Behind Chronic Inflammation
The findings offer new insights that could help guide the development of future therapies. A protein called human resistin may help flip on one of the immune system’s most powerful inflammatory switches. Researchers at [...]
Scientists Have Uncovered Previously Hidden Microbial Activity on Human Skin
The most abundant microbes on your skin may not be the ones doing most of the work. Human skin supports vast communities of bacteria, fungi, and viruses that can influence its protective barrier, immune [...]
Brazilian Tree Compounds Fight COVID-19 on Multiple Fronts
Scientists found compounds in a Brazilian tree that hit SARS-CoV-2 on multiple fronts, revealing a promising new lead in the search for COVID-19 treatments. Researchers have found that galloylquinic acids extracted from the leaves [...]
Cutting Two Amino Acids Slowed Prostate Cancer in Mice
A newly identified link between amino acid metabolism and cholesterol production may help prostate tumors adapt to hormone therapy. Prostate cancer can find ways around treatments designed to deprive tumors of the hormones they [...]
Largest-Ever Physics Survey Raises New Doubts About Our Model of the Universe
Physicists around the world remain deeply divided on key mysteries of the universe, from dark matter to quantum gravity. The standard cosmological model failed to gain majority support, and no leading theory dominated the [...]
Scientists Just Overturned a 100-Year-Old Belief About Bacteria in the Lungs
New findings raise questions about the role of microbes living in the lungs. More than 35 trillion bacteria live throughout the human body, forming microbiomes in the gut, mouth, lungs, skin, and urogenital tract. [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
